PBYI
Puma Biotechnology Inc
Company Overview
| Mkt Cap | $264.45M | Price | $5.10 |
| Volume | 431.72K | Change | -6.59% |
| P/E Ratio | 8.7 | Open | $5.43 |
| Revenue | $230.5M | Prev Close | $5.46 |
| Net Income | $30.3M | 52W Range | $2.32 - $6.07 |
| Div Yield | N/A | Target | $3.00 |
| Overall | 59 | Value | 80 |
| Quality | 36 | Technical | 63 |
No chart data available
Stock Overview
Updated DailyPuma Biotechnology Inc (PBYI) is a leading Healthcare company in the Biotechnology industry, currently trading at $5.10 with a market capitalization of $264.45 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows PBYI with a volume of 432K shares. The stock opened down 0.55% from yesterday's close of $5.46. Current analyst estimates project earnings of $0.52 per share for this year, with next year targeting $0.38.
PBYI demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ARRY, PFE, GSK.
Key investment considerations for PBYI include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -41.2%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 07:15 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PBYI | $5.10 | -6.6% | 431.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |